IDENTIFICATION OF RESTRICTIONS Sample Clauses

IDENTIFICATION OF RESTRICTIONS. Millennium shall identify at the earliest possible stage of the process of reviewing potential Druggable Targets the proprietary status of any gene sequence encoding a Druggable Target under consideration (e.g., whether it is derived from the [**], etc.) as well as any potential restrictions that would limit or otherwise affect Bayer's right to exploit in all human diseases and conditions Small Molecule drugs identified or developed using the Druggable Target.
Sample 1
AutoNDA by SimpleDocs
IDENTIFICATION OF RESTRICTIONS. Millennium shall identify, at the earliest possible stage of the process of reviewing potential Druggable Targets for status as QTs, the proprietary status of any gene sequence encoding the Druggable Target under consideration as a QT (e.g., whether it is derived from the [**], etc.) as well as any potential restrictions that would limit or otherwise affect Bayer's right to exploit in all human diseases and conditions Small Molecule drugs identified or developed using the Druggable Target.
Sample 1
IDENTIFICATION OF RESTRICTIONS. Millennium shall identify to Bayer at the earliest possible stage of the process of reviewing potential Conversion Targets the proprietary status of any gene sequence encoding a Conversion Target under consideration (e.g., whether it is derived from [**], etc.) as well as any potential restrictions that would limit or otherwise affect Bayer's rights set forth in Article IV to [**], including without limitation any royalty obligations or co-promotion or co-marketing rights relating to such Conversion Target and whether Millennium has in-licensed any rights from a Third Party relating to such Conversion Target.
Sample 1
IDENTIFICATION OF RESTRICTIONS. CuraGen shall use commercially reasonable efforts to identify at the earliest possible stage of the process of reviewing Target Candidates the proprietary status of any gene sequence encoding a Target Candidate (e.g., whether it is derived from public domain sources) as well as any potential restrictions that would limit or otherwise affect Bayer's right to exploit (i) QTs in all human diseases and conditions and (ii) Metabolic Program Drugs identified or developed using the Qualified Targets, and CuraGen shall promptly communicate their findings to Bayer. CuraGen will not [______________________________].
Sample 1

Related to IDENTIFICATION OF RESTRICTIONS

  • Termination of Restrictions Except as set forth in Section 9.3 hereof, the restrictions imposed by this Section 9 upon the transferability of Restricted Securities shall cease and terminate as to any particular Restricted Securities: (a) which shall have been effectively registered under the Securities Act, or (b) when, in the opinions of both counsel for the holder thereof and counsel for the Company, such restrictions are no longer required in order to insure compliance with the Securities Act or Section 10 hereof. Whenever such restrictions shall cease and terminate as to any Restricted Securities, the Holder thereof shall be entitled to receive from the Company, without expense (other than applicable transfer taxes, if any), new securities of like tenor not bearing the applicable legends required by Section 9.1 hereof.

  • Scope of Restrictions If the scope of any restriction contained in any preceding paragraphs of this Agreement is deemed too broad to permit enforcement of such restriction to its fullest extent, then such restriction shall be enforced to the maximum extent permitted by law, and Employee hereby consents and agrees that such scope may be judicially modified accordingly in any proceeding brought to enforce such restriction.

  • Removal of Restrictions Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan shall be released from escrow as soon as practicable after the last day of the Period of Restriction. The Committee, in its discretion, may accelerate the time at which any restrictions shall lapse, and remove any restrictions. After the restrictions have lapsed, the Participant shall be entitled to have any legend or legends under Section 7.4 removed from his or her Share certificate, and the Shares shall be freely transferable by the Participant.

  • Absence of Restrictions The Executive represents and warrants that the Executive is not bound by any employment contracts, restrictive covenants or other restrictions that prevent the Executive from entering into employment with, or carrying out the Executive’s responsibilities for, the Company, or which are in any way inconsistent with any of the terms of this Agreement.

  • Scope of Restriction If, at the time of enforcement of this paragraph 6, a court shall hold that the duration, scope or area restrictions stated herein are unreasonable under circumstances then existing, the parties hereto agree that the maximum duration, scope or area reasonable under such circumstances shall be substituted for the stated duration, scope or area.

  • Release of Restrictions Upon vesting of any portion of the shares of Restricted Stock and satisfaction of any other conditions required by the Plan or pursuant to this Restricted Stock Agreement, the Company shall promptly either issue a stock certificate, without such restricted legend, for any shares of the Restricted Stock that have vested, or, if the shares are held in book entry form, the Company shall remove the notations on the book form for any shares of the Restricted Stock that have vested.

  • Lapse of Restrictions If, for any reason, Shares are issued to the Employee within six months of the Grant Date, the Employee agrees that he or she will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the Grant Date.

  • Enforcement of Restrictions The parties hereby agree that any violation by Executive of the covenants contained in this Section 6 will likely cause irreparable damage to the Company or its subsidiaries and affiliates and may, as a matter of course, be restrained by process issued out of a court of competent jurisdiction, in addition to any other remedies provided by law.

  • Vesting and Lapse of Restrictions Subject to Sections 2.2(a) and 2.2(c), the Award shall vest and Restrictions shall lapse in accordance with the vesting schedule set forth on the Grant Notice.

  • Basic Restrictions (i) (1) No Person, other than an Excepted Holder, shall Beneficially Own or Constructively Own Shares in excess of the Aggregate Ownership Limit, (2) no Person, other than an Excepted Holder, shall Beneficially Own or Constructively Own Common Shares in excess of the Common Share Ownership Limit and (3) no Excepted Holder shall Beneficially Own or Constructively Own Shares in excess of the Excepted Holder Limit for such Excepted Holder.

Time is Money Join Law Insider Premium to draft better contracts faster.